Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “A-Thalassemia”

227 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 227 results

Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Testing effectiveness (Phase 2)Ended earlyNCT01459718
What this trial is testing

Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload

Who this might be right for
Transfusion-dependent β-thalassemia PatientsCardiac Iron Overload
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT06581627
What this trial is testing

A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

Who this might be right for
Healthy VolunteersSickle Cell DiseaseThalassemia
Novo Nordisk A/S 24
Testing effectiveness (Phase 2)Study completedNCT00919503
What this trial is testing

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Who this might be right for
Non-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 98
Early research (Phase 1)Active Not RecruitingNCT03249831
What this trial is testing

A Blood Stem Cell Transplant for Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell DisorderHemoglobinopathies+2 more
City of Hope Medical Center 3
Post-approval studies (Phase 4)Study completedNCT02342145
What this trial is testing

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Who this might be right for
Beta-Thalassemia MajorGraft-versus-host Disease (GVHD)
Zhongming Zhang 205
Not applicableStudy completedNCT00427661
What this trial is testing

A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

Who this might be right for
Sickle Cell DiseaseThalassemiaHemoglobinopathies
University of Pittsburgh 8
Large-scale testing (Phase 3)Study completedNCT02906202
What this trial is testing

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Who this might be right for
Beta-Thalassemia
Genetix Biotherapeutics Inc. 24
Not applicableActive Not RecruitingNCT02692872
What this trial is testing

Screening for Alpha Thalassemia in Healthy Volunteers

Who this might be right for
Alpha Thalassemia
National Institute of Allergy and Infectious Diseases (NIAID) 367
Large-scale testing (Phase 3)Looking for participantsNCT05356195
What this trial is testing

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

Who this might be right for
Beta-ThalassemiaThalassemiaGenetic Diseases, Inborn+2 more
Vertex Pharmaceuticals Incorporated 15
Not applicableStudy completedNCT04678037
What this trial is testing

Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study

Who this might be right for
Sickle Cell DiseaseSickle Cell Hemoglobin CSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableUnknownNCT00481221
What this trial is testing

Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter

Who this might be right for
ThalassemiaIron Deficiency
HaEmek Medical Center, Israel 30,000
Testing effectiveness (Phase 2)Study completedNCT03763656
What this trial is testing

Pharmacokinetics of Oral Hydroxyurea Solution

Who this might be right for
Sickle Cell DiseaseSickle-Cell; Hemoglobin Disease, ThalassemiaSickle Cell-beta-thalassemia+1 more
Nova Laboratories Limited 33
Not applicableStudy completedNCT00456690
What this trial is testing

Endocrine and Nutritional Assessment in B Thalassemia Major

Who this might be right for
Thalassemia
HaEmek Medical Center, Israel 133
Post-approval studies (Phase 4)WithdrawnNCT02069886
What this trial is testing

Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia

Who this might be right for
Thalassemia (Transfusion Delendent)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Ended earlyNCT01363908
What this trial is testing

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-Thalassemia
Shire 30
Not applicableLooking for participantsNCT05799118
What this trial is testing

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia, BetaThalassemia Alpha+1 more
Cyprus Institute of Neurology and Genetics 30,000
Not applicableNot Yet RecruitingNCT07215975
What this trial is testing

A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East

Who this might be right for
β-thalassemia
Bristol-Myers Squibb 200
Large-scale testing (Phase 3)Looking for participantsNCT04064060
What this trial is testing

Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Who this might be right for
Myelodysplastic Syndromes (MDS)Beta-thalassemiaMyeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene 665
Load More Results